Research suggests that saffron extract has meaningful support for mood and emotional wellbeing, with evidence drawn from a substantial body of clinical literature including multiple randomized controlled trials, several meta-analyses pooling data from dozens of studies, and numerous systematic reviews — nearly all pointing in a consistent direction of benefit for mild-to-moderate depression and anxiety symptoms. Studies indicate that saffron has shown effects comparable to standard antidepressant medications, including SSRIs, in head-to-head comparisons, and international expert panels have included saffron among a small number of botanical compounds receiving positive clinical recommendations for depression. The breadth and consistency of this evidence is relatively uncommon for a single botanical ingredient, though researchers across several reviews note that trial quality, product standardization, and longer-term safety data remain areas requiring further investigation. A small number of reviews have flagged general safety considerations worth awareness, and most researchers emphasize that larger and more rigorously designed trials are still needed before definitive clinical guidance can be issued.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| An Examination into the Effects of a Saffron Extract (Affron) on Mood and Gen... | RCT | 2025 | Supports | 95 |
| affron(®) a novel saffron extract (Crocus sativus L.) improves mood in health... | RCT | 2017 | Supports | 95 |
| New horizons for the study of saffron (Crocus sativus L.) and its active ingr... | Meta-analysis | 2024 | Supports | 92 |
| The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Me... | Meta-analysis | 2019 | Supports | 90 |
| Saffron (Crocus sativus) for depression: a systematic review of clinical stud... | Systematic review | 2014 | Supports | 90 |
| A systematic review of randomized controlled trials examining the effectivene... | Systematic review | 2015 | Supports | 88 |
| Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in T... | Meta-analysis | 2025 | Supports | 85 |
| Exploring the Potential of Saffron as a Therapeutic Agent in Depression Treat... | Review | 2024 | Supports | 85 |
| Herbal medicines in the treatment of psychiatric disorders: 10-year updated r... | Systematic review | 2018 | Supports | 82 |
| Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Tre... | Review | 2022 | Supports | 80 |
| Herbal medicine for depression and anxiety: A systematic review with assessme... | Systematic review | 2018 | Supports | 80 |
| Comparative efficacy and tolerability of nutraceuticals for depressive disord... | Meta-analysis | 2025 | Supports | 78 |
| Clinician guidelines for the treatment of psychiatric disorders with nutraceu... | Meta-analysis | 2022 | Supports | 78 |
| Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update. | Review | 2022 | Supports | 75 |
| Nature against depression. | Review | 2012 | Supports | 75 |
| Depression and Its Phytopharmacotherapy-A Narrative Review. | Review | 2023 | Supports | 72 |